The global plasma fractionation market is segmented into Neurology, Haematology, Immunology, Rheumatology, Haemato-oncology, Critical Care, Pulmonology and Others. Among these, the Neurology segment is expected to have the fastest-growing market during the forecast period 2022-2028 according to precision business insights. It is attributed to the faster response of this drug in human body. Based on end user, the global plasma fractionation market is segmented into Hospitals, Clinics, Academic Institutes and Clinical Research Laboratories.